• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Virol. Optimizing Viral Protein Yield of Influenza Strain A/Vietnam/1203/2004 by Modification of the Neuraminidase Gene.

Giuseppe

Emeritus
J Virol. 2009 Feb 18. [Epub ahead of print]

Optimizing Viral Protein Yield of Influenza Strain A/Vietnam/1203/2004 by Modification of the Neuraminidase Gene.

Adamo JE, Liu T, Schmeisser F, Ye Z. - Division of Viral Products, CBER, U.S. Food and Drug Administration, Bethesda, MD 20892.

Preparation of high yield pre-pandemic influenza H5N1 strains has presented a challenge to both researchers and vaccine manufacturers.
The reasons for relatively low yield of the H5N1 strains are not fully understood, but might be partially dependent on the interactions between the hemagglutinin (HA) or neuraminidase (NA) surface glycoproteins with other influenza viral proteins.
In this study we have constructed chimeras between the A/Puerto Rico/8/34 (PR8) NA gene and the A/Vietnam/1203/2004 (VN1203) NA gene which have resulted in an increase in virus yield of the reassortant viruses without significant loss of NA activity.
By combining the amino-terminus of NA from the PR8 strain, with the carboxy-terminus of NA from VN1203, the surface epitopes unique to the H5N1 VN1203 NA glycoprotein are maintained. This reassortant virus, had a higher titer and total protein yield in eggs, grew to a higher titer, produced large plaques on MDCK cells, and retained NA activity.
This work describes a novel recombinant technique designed to increase yields of vaccine candidates for production of pandemic influenza vaccines. The relationship between the infectivity and protein yield of the reassortants is also discussed.

PMID: 19224999 [PubMed - as supplied by publisher]
-
------
 
Back
Top Bottom